Atlas Trials

PembRolIzuMab and Stereotactic Body Radiotherapy In Metastatic Non-small-cell lunG Cancer Patients

Clinical trial NCT03436056 · TERMINATED

Trial details

NCT number
NCT03436056
Sponsor
Royal Marsden NHS Foundation Trust
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Non-small-cell lunG Cancer
Start date
2018-03-01
Primary completion
2019-07-08
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.